Kraig Biocraft Laboratories Inc (KBLB)

[casper-pkt]

Agree Mike. I would have been fine waiting for updates if additional agreements were being constructed to the benefit the company. Would the "NY Based Financier" been of greater benefit than CSC, or at least complimentary as a second source of funding. Would that additional funding have allowed KBLB to reach is 'Production' goals quicker, would it have presented a less dilutive method for funding, and I guess to be fair to all possible scenarios as Mojo pointed out, did the deal simply fall through (or to add - did it not live up to what Kim was out to achieve, so it was rejected).....We can't really know.

However, IMO, if the NY firm was of significant benefit, I would hope that Kim would have simply ignored all the constant whining about news, length of quite periods, etc., and continued work on the agreement. I would agree with a likely response from some that this would negatively impact the PPS over time, but if the benefits had enough merit, that PPS shrinkage would have likely recovered. Thus, this would lead me to a possible theory that either the NY Firm didn't present enough benefit, or the amount of time it was going to take to finish the agreement was simply going to be to drawn out.

I appreciate the update from Kim, and sure hope that any decision made on this front wasn't done in haste to placate the whining crowd.

All IMO - GLTA